Alpha-Thalassemia

Alpha-thalassemia is a genetic blood disorder that affects the body's ability to produce enough healthy red blood cells. It involves the blood system, specifically the production of hemoglobin, which carries oxygen throughout the body. People with this condition have a reduced amount or absence of alpha-globin chains, a key part of hemoglobin. This leads to anemia, causing symptoms like fatigue, weakness, and pale skin. The severity of symptoms depends on how many alpha-globin genes are affected. In severe cases, it can cause serious health problems before or shortly after birth. Understanding this condition helps explain why some people have chronic anemia and related complications.

Alpha-thalassemia is a hereditary hemoglobinopathy characterized by decreased or absent synthesis of alpha-globin chains due to deletions or mutations in the HBA1 and HBA2 genes. This imbalance in globin chain production leads to ineffective erythropoiesis and hemolysis, resulting in varying degrees of microcytic hypochromic anemia. The clinical spectrum ranges from silent carrier states with minimal symptoms to hemoglobin H disease and the most severe form, hydrops fetalis, which is usually fatal in utero or shortly after birth. The disease is most common in populations from Southeast Asia, Africa, and the Mediterranean. Diagnosis and management are critical due to the risk of severe anemia and related complications such as extramedullary hematopoiesis and iron overload.